Thursday, August 17, 2017

Atreca Adds $35M

Redwood City-based Atreca, a developer of cancer treatments, announced this morning that it has raised $35M in a Series B funding. The funding was co-led by Wellington Management Company and an un-named healthcare focused fund, along with Cormorant Asset Management and others. Tito A. Serafini, Ph.D. is Atreca's President, Chief Executive Officer, and Co-Founder.